A prospective, double blind, superiority, randomized
placebo-controlled trial conducted to confirm the rapid onset
anti-suicidal benefits of ketamine in the short term and at six
weeks.
About the Podcast
We take the most popularly asked clinical questions monthly and create a class around the corresponding evidence. Our EBM podcast will offer a glimpse into the evidence covered, and listeners can follow up with our CE if interested in more information.